Given the fact that hypoxia and increased ROS are common conditions in the tumor microenvironment, it is possible that D6D expression in tumors results from the following pathway: Hypoxia/ROS → HIF-1α → SREBP-1c → D6D. This evidence concerns the gene SREBF1 and neoplasm.